PHILADELPHIA--(BUSINESS WIRE)--PolyMedix, Inc. (OTC BB: PYMX) announced today that the U.S. Patent and Trademark Office has issued the company U.S. Patent No. 10,471,028 for a patent relating to its antimicrobial compounds. The patent titled, Facially Amphiphilic Polymers as Anti-infective Agents allows compositions of matter and uses for a number of series of antimicrobial compounds for antibiotic and other anti-infective applications.
